hVIVO plc
hVIVO plc (OPORF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
oporf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
hVIVO plcYou OPORF | $241M | N/A | — | -$0.01 |
 Benchmark Holdings plc BHCCF | $225M | N/A | — | -$0.05 |
 China Evergrande New Energy Vehicle Group Limited EVGRF | $2M | N/A | — | -$1.10 |
 Frontage Holdings Corporation FGHQF | $304M | 44.63x | — | $0.00 |
 Hansa Biopharma AB (publ) HNSBF | $246M | N/A | — | -$6.58 |
 Orpea S.A. ORPEF | $241M | N/A | — | -$1.85 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for hVIVO plc (OPORF) measures how much investors pay for each dollar of the company's trailing earnings. OPORF's current PE ratio of N/A is calculated by dividing its stock price of $0.35 by its TTM earnings per share of -$0.01.
Frequently asked questions
OPORF pe ratio · 6 questionsOPORF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.35 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via OPORF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · hVIVO plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09